Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Girentuximab> ?p ?o }
Showing triples 1 to 63 of
63
with 100 triples per page.
- Girentuximab abstract "Girentuximab (trade name Rencarex) is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.Girentuximab was developed by Wilex AG.It works by triggering antibody-dependent cell-mediated cytotoxicity (ADCC). It does this by activating natural killer cells by binding to carbonic anhydrase IX.As of 2011 it is in a phase III trial for clear cell renal cell carcinoma.".
- Girentuximab atcPrefix "none".
- Girentuximab casNumber "916138-87-9".
- Girentuximab fdaUniiCode "539B57DFJF".
- Girentuximab wikiPageID "33025505".
- Girentuximab wikiPageLength "2531".
- Girentuximab wikiPageOutDegree "9".
- Girentuximab wikiPageRevisionID "708180884".
- Girentuximab wikiPageWikiLink Antibody-dependent_cell-mediated_cytotoxicity.
- Girentuximab wikiPageWikiLink Carbonic_anhydrase_9.
- Girentuximab wikiPageWikiLink Category:Monoclonal_antibodies.
- Girentuximab wikiPageWikiLink Clear_cell_renal_cell_carcinoma.
- Girentuximab wikiPageWikiLink Fusion_protein.
- Girentuximab wikiPageWikiLink Monoclonal_antibody.
- Girentuximab wikiPageWikiLink Natural_killer_cell.
- Girentuximab wikiPageWikiLink Renal_cell_carcinoma.
- Girentuximab wikiPageWikiLinkText "Girentuximab".
- Girentuximab wikiPageWikiLinkText "girentuximab".
- Girentuximab atcPrefix "none".
- Girentuximab c "6460".
- Girentuximab casNumber "916138".
- Girentuximab chemspiderid "none".
- Girentuximab h "10006".
- Girentuximab mabType "mab".
- Girentuximab molecularWeight "146.5".
- Girentuximab n "1718".
- Girentuximab o "2018".
- Girentuximab s "48".
- Girentuximab source "xi".
- Girentuximab target Carbonic_anhydrase_9.
- Girentuximab tradename "Rencarex".
- Girentuximab type "mab".
- Girentuximab unii "539".
- Girentuximab verifiedfields "changed".
- Girentuximab verifiedrevid "458274725".
- Girentuximab wikiPageUsesTemplate Template:Antineoplastic-drug-stub.
- Girentuximab wikiPageUsesTemplate Template:As_of.
- Girentuximab wikiPageUsesTemplate Template:Cascite.
- Girentuximab wikiPageUsesTemplate Template:Chemspidercite.
- Girentuximab wikiPageUsesTemplate Template:Drugbankcite.
- Girentuximab wikiPageUsesTemplate Template:Drugbox.
- Girentuximab wikiPageUsesTemplate Template:Fdacite.
- Girentuximab wikiPageUsesTemplate Template:Monoclonal-antibody-stub.
- Girentuximab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Girentuximab subject Category:Monoclonal_antibodies.
- Girentuximab hypernym Antibody.
- Girentuximab type ChemicalSubstance.
- Girentuximab type Drug.
- Girentuximab type Antibody.
- Girentuximab type Chemical.
- Girentuximab type Drug.
- Girentuximab type ChemicalObject.
- Girentuximab type Thing.
- Girentuximab type Q8386.
- Girentuximab comment "Girentuximab (trade name Rencarex) is a chimeric monoclonal antibody designed for the treatment of renal cell carcinoma.Girentuximab was developed by Wilex AG.It works by triggering antibody-dependent cell-mediated cytotoxicity (ADCC). It does this by activating natural killer cells by binding to carbonic anhydrase IX.As of 2011 it is in a phase III trial for clear cell renal cell carcinoma.".
- Girentuximab label "Girentuximab".
- Girentuximab sameAs Q5564223.
- Girentuximab sameAs جيرنتوكسيماب.
- Girentuximab sameAs Girentuximab.
- Girentuximab sameAs m.0h54zbv.
- Girentuximab sameAs Q5564223.
- Girentuximab wasDerivedFrom Girentuximab?oldid=708180884.
- Girentuximab isPrimaryTopicOf Girentuximab.